Non-B Non-C Liver Cirrhosis
Conditions
Brief summary
To study the etiologies of patients diagnosed as non-B, non-C liver cirrhosis (NBNC-LC). To describe the different patient's outcomes.
Detailed description
Liver cirrhosis is the ultimate fate of many hepatic insults that may be viral, immunologic, and metabolic or even cryptogenic. (Tsochatzis EA et al., 2014) Recently, Non-Alcoholic Fatty Liver Disease (NAFLD) present a serious health burden worldwide that affects around 25% of the global adult population with a prevalence of around 31.8% in the Middle East. (Younossi ZM, et al., 2019) Most of Egyptian patients presented with end-stage liver disease are secondary to post-hepatitic cirrhosis is estimated to be more than 80% of cases. (Guerra J et al., 2012) The real profile of non-B, non-C etiologies of liver cirrhosis, in Egyptian patients, is still not fully evaluated.
Interventions
DIAGNOSTIC_TESTDiagnostic tests
Diaagnostic tests for all pt diagnosed as Non-B Non-C Liver Cirrhosis
Sponsors
Assiut University
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Inclusion criteria
* All pateints diagnosed as Non-B Non-C Liver Cirrhosis in the period from 2017\_2023
Exclusion criteria
* We will exclude the pateints that will be diagnosed as HBV-HCV induced Liver Cirrosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of different etiologies of liver cirrhosis that not related to HBV or HCV in our community | Base line |
Secondary
| Measure | Time frame |
|---|---|
| Detection of the most common etiologies of Non B Non C liver cirrhosis in our community | Baseline |
Contacts
Primary ContactAbdelrahman Mohammed Abdelrahman Morsi
Backup ContactMagda Shehata Hassan
Outcome results
None listed